106 related articles for article (PubMed ID: 17145571)
1. Iron sucrose induced morphological and functional changes in the rat kidney.
Breborowicz A; Polubinska A; Górna K; Breborowicz M; Oreopoulos DG
Transl Res; 2006 Nov; 148(5):257-62. PubMed ID: 17145571
[TBL] [Abstract][Full Text] [Related]
2. Effect of peritoneal dialysis on renal morphology and function.
Breborowicz A; Pawlaczyk K; Polubinska A; Górna K; Wieslander A; Carlsson O; Tam P; Wu G
Nephrol Dial Transplant; 2006 Dec; 21(12):3539-44. PubMed ID: 16968722
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal effects of intravenous iron sucrose administration in rats.
Breborowicz A; Polubinska A; Breborowicz M; Simon M; Wanic-Kossowska M; Oreopoulos DG
Transl Res; 2007 Jun; 149(6):304-9. PubMed ID: 17543848
[TBL] [Abstract][Full Text] [Related]
4. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
5. Reversal of iron-induced nephrotoxicity in rats by molsidomine, a nitric oxide donor.
Gupta A; Sharma S; Chopra K
Food Chem Toxicol; 2008 Feb; 46(2):537-43. PubMed ID: 17935848
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Sodium nitroprusside and L-arginine attenuates ferric nitrilotriacetate-induced oxidative renal injury in rats.
Gupta A; Chander V; Sharma S; Chopra K
Toxicology; 2007 Apr; 232(3):183-91. PubMed ID: 17280760
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity.
Corley RA; Wilson DM; Hard GC; Stebbins KE; Bartels MJ; Soelberg JJ; Dryzga MD; Gingell R; McMartin KE; Snellings WM
Toxicol Appl Pharmacol; 2008 Apr; 228(2):165-78. PubMed ID: 18191429
[TBL] [Abstract][Full Text] [Related]
9. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
10. Alteration of mRNA expression of molecules related to iron metabolism in adenine-induced renal failure rats: a possible mechanism of iron deficiency in chronic kidney disease patients on treatment.
Hamada Y; Kono TN; Moriguchi Y; Higuchi M; Fukagawa M
Nephrol Dial Transplant; 2008 Jun; 23(6):1886-91. PubMed ID: 18174266
[TBL] [Abstract][Full Text] [Related]
11. Effect of saccharated ferric oxide and iron dextran on the metabolism of phosphorus in rats.
Sanai T; Oochi N; Okada M; Imamura K; Okuda S; Iida M
J Lab Clin Med; 2005 Jul; 146(1):25-9. PubMed ID: 16025088
[TBL] [Abstract][Full Text] [Related]
12. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
Song J; Meng L; Li S; Qu L; Li X
Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
[TBL] [Abstract][Full Text] [Related]
13. Chitosan iron(III) reduces phosphorus levels in alloxan diabetes-induced rats with signs of renal failure development.
Schöninger LM; Dall'Oglio RC; Sandri S; Rodrigues CA; Bürger C
Basic Clin Pharmacol Toxicol; 2010 Jun; 106(6):467-71. PubMed ID: 20070292
[TBL] [Abstract][Full Text] [Related]
14. Effects of subchronic exposure via drinking water to a mixture of eight water-contaminating metals: a biochemical and histopathological study in male rats.
Jadhav SH; Sarkar SN; Patil RD; Tripathi HC
Arch Environ Contam Toxicol; 2007 Nov; 53(4):667-77. PubMed ID: 17882470
[TBL] [Abstract][Full Text] [Related]
15. Renoprotective effects of sesamol in ferric nitrilotriacetate-induced oxidative renal injury in rats.
Gupta A; Sharma S; Kaur I; Chopra K
Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):316-21. PubMed ID: 19281599
[TBL] [Abstract][Full Text] [Related]
16. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
Tagboto S; Cropper L; Mostafa S; Turner J; Bailey G; Pugh-Clarke K
J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076
[TBL] [Abstract][Full Text] [Related]
17. Tissue iron distribution and adaptation of iron absorption in rats exposed to a high dietary level of NaFeEDTA.
Yeung CK; Zhu L; Glahn RP; Miller DD
J Agric Food Chem; 2005 Oct; 53(20):8087-91. PubMed ID: 16190675
[TBL] [Abstract][Full Text] [Related]
18. Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?
Sav T; Tokgoz B; Sipahioglu MH; Deveci M; Sari I; Oymak O; Utas C
Ren Fail; 2007; 29(4):423-6. PubMed ID: 17497463
[TBL] [Abstract][Full Text] [Related]
19. Intravenous iron sucrose changes the intraperitoneal homeostasis.
Breborowicz A; Połubinska A; Kupczyk M; Wanic-Kossowka M; Oreopoulos DG
Blood Purif; 2009; 28(1):53-8. PubMed ID: 19325240
[TBL] [Abstract][Full Text] [Related]
20. Renal impairment in experimental hemochromatosis in rats.
May ME; May EE; Parmley RT; Spicer SS; Buse MG
Horm Metab Res; 1983 Apr; 15(4):194-6. PubMed ID: 6862358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
